Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Our Injection Options Quick, Convenient, and Designed for Your Schedule Busy schedule but still want to feel your best
The MHRA authorised a Wegovy semaglutide tablet for weight management in June 2026
A related drug called tirzepatide (brand name Zepbound) was approved for weight loss in November of this year
The XPrize Foundation is led by executive chairman Peter Diamandis, also an active promoter of longevity research
The injection itself takes less than one minute and can be given in the abdomen, thigh, or upper armareas with adequate subcutaneous fat tissue
According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported side effects include nausea, vomiting, diarrhoea, abdominal pain, and constipation
US$ 24.67
US$ 21.68
US$ 29.89
